Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
6.93
-0.48 (-6.50%)
Jun 23, 2026, 1:45 PM EDT - Market open
Basel Medical Group Revenue
In the fiscal year ending June 30, 2025, Basel Medical Group had annual revenue of 11.35M SGD with 12.97% growth. Basel Medical Group had revenue of 6.31M in the half year ending June 30, 2025, with 34.15% growth.
Revenue (ttm)
11.35M SGD
Revenue Growth
+12.97%
P/S Ratio
1.23
Revenue / Employee
138,475 SGD
Employees
82
Market Cap
10.85M USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 11.35M | 1.30M | 12.97% |
| Jun 30, 2024 | 10.05M | 304.04K | 3.12% |
| Jun 30, 2023 | 9.75M | -911.62K | -8.55% |
| Jun 30, 2022 | 10.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBMGL News
- 4 days ago - Basel Medical Group Ltd trading halted, news pending - TheFly
- 13 days ago - QingSong Health Corp (2661.HK) and Basel Medical Sign Strategic Cooperation Memorandum to Explore AI Healthcare Services in Southeast Asia - PRNewsWire
- 13 days ago - Basel Medical to effect 1-for-12 reverse share split - TheFly
- 13 days ago - BMGL to Effect Reverse Share Split on June 22, 2026 - GlobeNewsWire
- 3 months ago - Basel Medical resolves Nasdaq filing deficiency - TheFly
- 3 months ago - Compliance With Nasdaq Periodic Filing Requirement - GlobeNewsWire
- 5 months ago - Basel Medical receives noncompliance notification from Nasdaq - TheFly
- 5 months ago - Receipt of Delinquency Notification from Nasdaq - GlobeNewsWire